Compound Detail
CHEMBL3781491
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc2c(cc1OC)CN(CCc1ccc(-n3cc(COc4ccccc4[N+](=O)[O-])nn3)cc1)CC2
Basic Information
| ChEMBL ID | CHEMBL3781491 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WSGYQHXYDDMALU-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
515.6
MW (Da)
4.37
ALogP
9
HBA
0
HBD
104.8
PSA (Ų)
0.23
QED
1
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 5.29
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 5110.0 | nM | 5.29 | Reversal of P-gp-mediated resistance to adriamycin in human K562/A02 cells asses... | 27073052 |
| K562 | IC50 | = | 48770.0 | nM | 4.31 | Cytotoxicity against human K562 cells assessed as cell viability after 48 hrs by... | 27073052 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 27073052 | 10.1016/j.bmc.2016.03.065 | Unchecked | 2 |
| 27073052 | 10.1016/j.bmc.2016.03.065 | K562 | 1 |
| 27073052 | 10.1016/j.bmc.2016.03.065 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine